Daniel Gooding
Fondatore presso NUFORMIX PLC
Profilo
Daniel Gooding founded Nuformix Technologies Ltd.
in 2007, where he worked as Chief Executive Officer & Director from 2007 to 2020 and Nuformix Plc in 2008, where he is working as Executive Director.
Dr. Gooding received his doctorate degree from the University of Leeds.
Posizioni attive di Daniel Gooding
| Società | Posizione | Inizio |
|---|---|---|
| NUFORMIX PLC | Fondatore | 01/01/2008 |
Precedenti posizioni note di Daniel Gooding
| Società | Posizione | Fine |
|---|---|---|
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Fondatore | 01/06/2020 |
Formazione di Daniel Gooding
| University of Leeds | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NUFORMIX PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Daniel Gooding
